We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Optimizing Prograf® Therapy in Renal Transplant Patients (OPTIMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00297765
Recruitment Status : Completed
First Posted : March 1, 2006
Last Update Posted : August 26, 2008
Astellas Pharma US, Inc.
Information provided by:
Astellas Pharma Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : March 2006